insights_auto
Why is 4519 up 2,51%?
Dive Deeperchevron_right
4519:TYO
Chugai Pharmaceutical Co Ltd
6 170,00 JPY
arrow_upward
+2,51%(+151,00) 1D
13 ოქტ, 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
6 100 JPY
High
6 170 JPY
Low
6 078 JPY
Mkt. cap
10,36 ტრლ.
Avg. vol.
2,99 მლნ.
Volume
2,64 მლნ.
Dividend
2,24%
Quarterly dividend
34 JPY
Ex-dividend date
29 ივნ. 2026
P/E ratio
21,54
52-wk high
10 700 JPY
52-wk low
5 974 JPY
EPS
286 JPY
Shares outstanding
547,19 მლნ.
No. of employees
5 ათ.
Open
6 100 JPY
High
6 170 JPY
Low
6 078 JPY
Mkt. cap
10,36 ტრლ.
Avg. vol.
2,99 მლნ.
Volume
2,64 მლნ.
Dividend
2,24%
Quarterly dividend
34 JPY
Ex-dividend date
29 ივნ. 2026
P/E ratio
21,54
52-wk high
10 700 JPY
52-wk low
5 974 JPY
EPS
286 JPY
Shares outstanding
547,19 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
11 საათის წინ
Chugai reports Week 52 vamikibart data for Chugai Pharmaceutical stock
ad-hoc-news.de
·
23 საათის წინ
Chugai Pharmaceutical stock after-hours at EUR 33.94
ad-hoc-news.de
·
1 დღის წინ
Chugai Pharmaceutical stock at EUR 34.02, market value JPY 9.9 trillion
ad-hoc-news.de
·
1 დღის წინ
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOოსამუ ოკუდა
Employees5,1 ათ.
Founded10 მარ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp